Qing Peng
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 02, 2024
Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy.Liyuan Hao, Shenghao Li, Qing Peng
|Dec 28, 2022
Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.Qing Peng, Shenghao Li, Xinli Shi
|Sep 06, 2022
Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.Qing Peng, Liyuan Hao, Yinglin Guo
|Jun 20, 2022
The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.Jingmin Ji, Zhiqin Zhang, Qing Peng
Pageof 1